News
The firm posted net losses of US$4.4 million and US$6.1 million, respectively, for the fiscal years ended June 2024 and 2023 ...
Nasdaq-listed shares of money-losing Regencell Bioscience Holdings exploded 82,000 per cent higher before they plunged. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback